NO851877L - Nye terapeutisk virksomme pyrimidinforbindelser og fremgangsmaater til deres fremstilling. - Google Patents
Nye terapeutisk virksomme pyrimidinforbindelser og fremgangsmaater til deres fremstilling.Info
- Publication number
- NO851877L NO851877L NO851877A NO851877A NO851877L NO 851877 L NO851877 L NO 851877L NO 851877 A NO851877 A NO 851877A NO 851877 A NO851877 A NO 851877A NO 851877 L NO851877 L NO 851877L
- Authority
- NO
- Norway
- Prior art keywords
- amine
- methoxyphenyl
- methyl
- pyrimidin
- phenylpyrimidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848412184A GB8412184D0 (en) | 1984-05-12 | 1984-05-12 | Biologically active nitrogen heterocycles |
GB858500417A GB8500417D0 (en) | 1985-01-08 | 1985-01-08 | Biologically active nitrogen heterocycles |
Publications (1)
Publication Number | Publication Date |
---|---|
NO851877L true NO851877L (no) | 1985-11-13 |
Family
ID=26287736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO851877A NO851877L (no) | 1984-05-12 | 1985-05-10 | Nye terapeutisk virksomme pyrimidinforbindelser og fremgangsmaater til deres fremstilling. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0164204A1 (en, 2012) |
AU (1) | AU4227685A (en, 2012) |
DK (1) | DK203985A (en, 2012) |
ES (1) | ES8609275A1 (en, 2012) |
FI (1) | FI851837A7 (en, 2012) |
GR (1) | GR851131B (en, 2012) |
IL (1) | IL75147A0 (en, 2012) |
NO (1) | NO851877L (en, 2012) |
PT (1) | PT80432B (en, 2012) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4711888A (en) * | 1985-07-24 | 1987-12-08 | Pfizer Inc. | Hydroxy and alkoxy pyrimidines |
DE3751742T3 (de) * | 1986-01-13 | 2002-11-21 | American Cyanamid Co., Wayne | 4,5,6-Substituierte 2-Pyrimidinamine |
GB8903592D0 (en) * | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
US5064963A (en) * | 1990-04-25 | 1991-11-12 | American Cyanamid Company | Process for the synthesis of n-(3-(1h-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidinamines |
CA2365269A1 (en) * | 1991-01-31 | 1992-08-20 | Warner-Lambert Company | Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
US5177079A (en) * | 1991-01-31 | 1993-01-05 | Warner-Lambert Company | 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
US5248682A (en) * | 1991-01-31 | 1993-09-28 | Warner-Lambert Company | 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
US5270319A (en) * | 1991-09-09 | 1993-12-14 | Warner-Lambert Company | 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents |
US5220025A (en) * | 1992-02-24 | 1993-06-15 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
US5196431A (en) * | 1992-02-24 | 1993-03-23 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
US5276186A (en) * | 1992-03-11 | 1994-01-04 | Ciba-Geigy Corporation | Process for the production of guanidine derivatives |
US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
US5516775A (en) * | 1992-08-31 | 1996-05-14 | Ciba-Geigy Corporation | Further use of pyrimidine derivatives |
US5543520A (en) * | 1993-10-01 | 1996-08-06 | Ciba-Geigy Corporation | Pyrimidine derivatives |
ATE208772T1 (de) * | 1993-10-01 | 2001-11-15 | Novartis Erfind Verwalt Gmbh | Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung |
JPH08503971A (ja) * | 1993-10-01 | 1996-04-30 | チバ−ガイギー アクチェンゲゼルシャフト | ピリミジンアミン誘導体及びその調製のための方法 |
JP2000506532A (ja) | 1996-03-13 | 2000-05-30 | スミスクライン・ビーチャム・コーポレイション | サイトカイン介在疾患の治療にて有用な新規ピリミジン化合物 |
US6184226B1 (en) | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
GB2361236B (en) | 2000-03-29 | 2002-04-24 | Cyclacel Ltd | Pyrimidines useful against proliferative disorders |
MXPA04004178A (es) | 2001-11-01 | 2004-09-06 | Janssen Pharmaceutica Nv | Heteroarilaminas como inhibidores de glucogeno cintasa cinasa 3beta. |
NZ531854A (en) * | 2001-11-01 | 2006-03-31 | Janssen Pharmaceutica Nv | Aminobenzamide derivatives as glycogen synthase kinase 3beta inhibitors |
AR038368A1 (es) | 2002-02-01 | 2005-01-12 | Novartis Ag | Compuestos n-pirimidin-2-il-aminas sustituidas como inhibidores de ige, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de un medicamento |
CA2533474A1 (en) | 2003-07-30 | 2005-02-10 | Shudong Wang | 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
JP4790703B2 (ja) * | 2004-04-07 | 2011-10-12 | 武田薬品工業株式会社 | 環式化合物 |
CA2576159A1 (en) | 2004-08-27 | 2006-03-02 | Cyclacel Limited | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
KR101415426B1 (ko) | 2005-09-27 | 2014-07-04 | 아이알엠 엘엘씨 | 디아릴아민-함유 화합물 및 조성물, 및 c-kit 수용체의조절제로서의 그의 용도 |
GB0606774D0 (en) * | 2006-04-03 | 2006-05-10 | Novartis Ag | Organic compounds |
JP5160636B2 (ja) | 2007-05-04 | 2013-03-13 | アイアールエム・リミテッド・ライアビリティ・カンパニー | c−kitおよびPDGFRキナーゼ阻害剤としてのピリミジン誘導体および組成物 |
AU2008289037B2 (en) * | 2007-08-22 | 2012-03-01 | Novartis Ag | 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
ES2368876T3 (es) | 2007-08-22 | 2011-11-23 | Irm Llc | Derivados de 2-heteroarilaminopirimidina como inhibidores de cinasa. |
WO2009143183A1 (en) * | 2008-05-19 | 2009-11-26 | University Of Tennessee Research Foundation, The | Pyrimidine non-classical cannabinoid compounds and related methods of use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3496179A (en) * | 1967-10-11 | 1970-02-17 | Pfizer & Co C | 2-amino-3,4-dihydroquinazolines |
US3635979A (en) * | 1969-09-29 | 1972-01-18 | Pfizer | Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines |
CA961855A (en) * | 1969-10-16 | 1975-01-28 | Eli Lilly And Company | Immunosuppressants and anti-viral agents |
US3900476A (en) * | 1973-05-17 | 1975-08-19 | Upjohn Co | 2(2'-pyrimidylamino)quinazolines and their preparation |
US4010269A (en) * | 1975-06-16 | 1977-03-01 | The Upjohn Company | Antiviral quinazoline compositions and methods of use |
DE3220118A1 (de) * | 1982-05-28 | 1983-12-01 | Bayer Ag, 5090 Leverkusen | Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1985
- 1985-04-25 EP EP85302902A patent/EP0164204A1/en not_active Withdrawn
- 1985-05-08 DK DK203985A patent/DK203985A/da not_active Application Discontinuation
- 1985-05-09 FI FI851837A patent/FI851837A7/fi not_active Application Discontinuation
- 1985-05-09 GR GR851131A patent/GR851131B/el unknown
- 1985-05-09 IL IL75147A patent/IL75147A0/xx unknown
- 1985-05-10 NO NO851877A patent/NO851877L/no unknown
- 1985-05-10 PT PT80432A patent/PT80432B/pt unknown
- 1985-05-10 ES ES543047A patent/ES8609275A1/es not_active Expired
- 1985-05-10 AU AU42276/85A patent/AU4227685A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK203985A (da) | 1985-11-13 |
AU4227685A (en) | 1985-11-14 |
GR851131B (en, 2012) | 1985-11-25 |
ES8609275A1 (es) | 1986-07-16 |
ES543047A0 (es) | 1986-07-16 |
FI851837A0 (fi) | 1985-05-09 |
FI851837L (fi) | 1985-11-13 |
IL75147A0 (en) | 1985-09-29 |
FI851837A7 (fi) | 1985-11-13 |
DK203985D0 (da) | 1985-05-08 |
PT80432A (en) | 1985-06-01 |
PT80432B (en) | 1987-04-16 |
EP0164204A1 (en) | 1985-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO851877L (no) | Nye terapeutisk virksomme pyrimidinforbindelser og fremgangsmaater til deres fremstilling. | |
AU2008252380B2 (en) | Quinazolin-oxime derivatives as Hsp90 inhibitors | |
US5977118A (en) | 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and compositions and methods of use thereof | |
KR100626605B1 (ko) | 신규 피리다진 유도체 및 이를 유효성분으로 하는 의약 | |
EP0055583B1 (en) | Antihypertensives | |
AU7163196A (en) | Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions | |
US7262202B2 (en) | Inhibitors of cyclin dependent kinases as anti-cancer agent | |
US4515948A (en) | 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines | |
DK150142B (da) | Analogifremgangsmaade til fremstilling af 5-(2-imidazolin-2-yl)-aminopyrimidiner eller syreadditionssalte deraf | |
HUP0203477A2 (hu) | Alkil-amino-helyettesített biciklikus nitrogén-heterociklusok mint P38 protein-kináz-inhibitorok, ezeket tartalmazó gyógyszerkészítmények és előállítási eljárásaik | |
GB2087881A (en) | 5-substituted methyl-pyrimidine-2,4-diamines | |
CA2031328A1 (en) | Xanthine derivatives, their production and use | |
NZ504465A (en) | 1-Phenylacylamino substituted piperazine derivatives which are 4-substituted by a heteroaryl group | |
CZ297798A3 (cs) | Farmaceuticky vhodné isochinolinové deriváty a způsob jejich přípravy | |
US6080750A (en) | Pyrimidine compound and anti-rotavirus composition | |
NO841168L (no) | Fremgangsmaate for fremstilling av pyrimidinderivater | |
EP0077983B1 (en) | Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same | |
EP0208518B1 (en) | 6-phenyl-pyridazinyl compounds | |
CA2249420A1 (en) | 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors | |
RU2328495C2 (ru) | Производное бензофурана | |
PL210470B1 (pl) | Związki 4-imidazolin-2-onu i jego zastosowanie | |
RU2116308C1 (ru) | Триазолпиримидиновые производные и фармацевтическая композиция | |
US4666915A (en) | 2-anilino-1,6-dihydro-6-oxo-5-pyrimidine-carboxylic acid derivatives, process for the preparation thereof, and antiallergic agent containing the same | |
US5698564A (en) | Diphenyl disulfide compounds | |
CA2794952A1 (en) | Compounds and method for treatment of hiv |